Ip Life Sciences Exchange

The IP Life Sciences Exchange is the leading networking and benchmarking event for European senior IP decision makers from the life sciences sector. The popular format brings together Directors of IP plus a selected group of innovative solution and service providers.

Focusing on IP strategy, portfolio management, Unified Patent developments, the latest life sciences case law and biosimilars developments plus emerging markets challenges, attendees tailor their agenda by selecting case studies, debates, group discussions, interactive BrainWeaves and one-on-one business meetings.

Expert speakers this year will include:
• Pfizer, Assistant General Counsel
• Zealand Pharma, Head of Patent Department
• Merck Group, Head of Patents Pharmaceuticals
• Novartis Pharma, Head Global Patent Litigation Strategy
• Syngenta AG, Head of IP

The IP Life Sciences Exchange events have become the place to be for combining networking, learning and benchmarking. Don't just take our word for it - hear from the past attendees:

“Very interesting and professional. The mix between talks, round tables, and personal meetings was very good” B.G. Negev Technologies and Applications Ltd., Intellectual Property Director, Life Sciences

“Great networking invent during which I learned a lot about IP from the generics company perspective” AC Immune SA, Head of IP

For more information or to register:
Tel: +44 207 368 9484
Email: exchangeinfo@iqpc.com
Visit: http://bit.ly/2937xeu

On Tuesday November 15, 2016 at 8:00 am (ends Wednesday November 16, 2016 at 6:00 pm)

Category: Conferences

Price:

Delegate: GBP 1950

Venue: TBA, TBA, Munich, 80331

Links:

Website: https://go.evvnt.com/61775-0